openPR Logo
Press release

Pyrogen Testing Market to Surpass US$ 1.9 Billion by 2026 | Thermo Fisher Scientific, Merck KGaA, Lonza Group, Associates of Cape Cod Inc

08-12-2020 02:19 PM CET | Health & Medicine

Press release from: Coherent Market Insights (CMI)

Pyrogen Testing Market

Pyrogen Testing Market

Pyrogen testing is used in detection of pyrogen contamination in pharmaceutical dosage forms and medical devices. Pyrogen contaminated injections post administration can cause temperature dysregulation (fever), bodyache, inflammation, shock, multiorgan failure, and other life threatening problems.

Moreover, increasing research and development of therapeutic drugs and medical devices is propelling growth of the pyrogen testing market over the forecast period. According to the United Nations Educational, Scientific and Cultural Organization (UNESCO), November 2016, an estimated US$ 1.7 trillion of global spending in research and development for various medical applications. Moreover, the U.S. Food and Drug Administration (FDA) and its Center for Drug Evaluation and Research (CDER), has approved around 59 novel drugs in 2018 compared to 46 approvals of new molecule entities in 2017.

Increasing launch of advanced devices by market players to augment the market growth Key players in the market are focused on development of devices for detection of pyrogen in pharmaceutical products. For instance, in March 2014, Pyrosate rapid endotoxin detection kit developed by Associates of Cape Cod, Inc., received approval from the Food and Drugs Administration (FDA) for performing endotoxin assays. Similarly, in May 2018, bioMérieux announced the launch of ENDOZYME II GO, which enables detection of endotoxin testing in pharmaceutical water grades, parenteral drugs, and other pharmaceutical products. Moreover, high investment in research & development and quality assurance by key players is expected to boost the market growth. For instance, in October 2014, new research and development center was inaugurated by bioMérieux for development of new diagnostic solutions in microbiology and increase the efficiency of laboratory procedures.

Request a sample report @ https://www.coherentmarketinsights.com/insight/request-sample/243

Key players in the market are focused on adopting strategies such as mergers and acquisitions to enhance its product portfolio. For instance, in January 2017, Merck acquired BioControl System Inc., with a strategy to penetrate in food and beverage space and strengthen its portfolio in food pathogen testing.

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pyrogen Testing Market to Surpass US$ 1.9 Billion by 2026 | Thermo Fisher Scientific, Merck KGaA, Lonza Group, Associates of Cape Cod Inc here

News-ID: 2110741 • Views: 561

More Releases from Coherent Market Insights (CMI)

Upcomeing Trend of the oncology biosimilars market over the forecast to 2026 | A …
In approval of first biosimilars in two key markets, Europe and the U.S. First biosimilar was approved in 2006 in Europe, however, in the U.S. first product was approved in 2015. But since approving the first biosimilar, the FDA has approved five products in 2017. Out of these five biosimilars, two were approved for oncology. First, oncology biosimilar Mvasi (bevacizumab-awwb) received approval in September 2017, and second one, Ogivri (trastuzumab)
Increasing Drug Approvals Are Attributing To The Highest Share Of North America …
Regional oncology drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America oncology drugs market holds dominant position in the global oncology drugs market. Advanced medical treatment options available for cancer in economies such as the U.S. and increasing survival rate are key factors driving the market growth. For instance, according to the American Association for Cancer Research’s 2015 report, the number
Plant-based Vaccines Market - Research & Development (R&D) Activities | Medicago …
Plant-based vaccines market are focused on extensive clinical trial studies to develop plant-based vaccines for numerous therapeutic applications. For instance, Medicago Inc., a clinical-stage biotechnology company, which uses plant-based technologies to develop and produce novel vaccine and antibodies, is cultivating several tobacco plants (Nicotiana tabacum) at Durham's Research Triangle Park, North America, which will be used in testing and production of the flu vaccine. In March 2018, Medicago conducted phase
Cervical Cancer Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2 …
Increasing funding for cancer research, rising insurance coverage, and increase in the number of new targeted cancer drugs are expected to support the revenue growth of cervical cancer drugs market. For instance, National Cancer Institute, in 2015, spent around US$ 4,480 million on cancer research, which include cervical cancer, lung cancer, colorectal cancer, liver cancer, breast cancer, leukaemia, ovarian cancer, and uterine cancer. Furthermore, according to the American Cancer Society,

All 5 Releases


More Releases for Pyrogen

Set Limit on Pyrogen Concentration to Drive the Demand for Pyrogen Testing in Ph …
Pyrogen is a type of microbial and non-microbial substance that causes fever. Hence, pyrogen testing is conducted to measure the presence of pyrogen that causes fever. Medical devices manufacturers and pharmaceutical companies also focus on conducting pyrogen testing to assess the concentration level of pyrogen, to ensure that it is within the prescribed limit. Moreover, regulatory bodies across the globe are also introducing regulations to ensure public safety. Majority
Set Limit on Pyrogen Concentration to Drive the Demand for Pyrogen Testing in Ph …
Pyrogen is a type of microbial and non-microbial substance that causes fever. Hence, pyrogen testing is conducted to measure the presence of pyrogen that causes fever. Medical devices manufacturers and pharmaceutical companies also focus on conducting pyrogen testing to assess the concentration level of pyrogen, to ensure that it is within the prescribed limit. Moreover, regulatory bodies across the globe are also introducing regulations to ensure public safety. Majority
Set Limit on Pyrogen Concentration to Drive the Demand for Pyrogen Testing in Ph …
Pyrogen is a type of microbial and non-microbial substance that causes fever. Hence, pyrogen testing is conducted to measure the presence of pyrogen that causes fever. Medical devices manufacturers and pharmaceutical companies also focus on conducting pyrogen testing to assess the concentration level of pyrogen, to ensure that it is within the prescribed limit. Moreover, regulatory bodies across the globe are also introducing regulations to ensure public safety. Majority
Pyrogen Testing Market — Global Industry Insights, Trends, 2024
Pyrogen testing is used to measure the presence of pyrogen in an organism that causes fever. Pyrogens are substances that can cause fever and these substances can be found in lipopolysaccharides and lepoteichoic acid. Pyrogen contamination can be found in pharmaceutical drugs & medical devices and thus, it is essential for healthcare companies to conduct pyrogen testing to assess concentration level for pyrogens and ensure that it is well within
Pyrogen Testing Market Professional Survey Report 2024
Global Pyrogen Testing Market: Snapshot The global pyrogen testing market has been witnessing a rapid growth rate in recent years as the pharmaceutical, medical devices, and biotechnology industries are undergoing a huge change. The growing support from governments to launch new drugs to fight several new diseases has augmented the demand for pyrogen testing in the past few decades. Pyrogens are known to cause fever and body ache after being injected.
Global Pyrogen Testing Market Research Report 2017
Pyrogen Testing Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Request Sample Report: http://www.reportbazzar.com/request-sample/?pid=812213&ptitle=Global+Pyrogen+Testing+Market+Research+Report+2017&req=Sample The report firstly introduced the Pyrogen Testing basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes;